
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
TO STUDY THE PRESCRIPTION ANALYSIS OF TUBERCULOSIS DRUGS AND MAINTAINING THE SAFETY AND EFFICACY OF TUBERCULOSIS DRUG
*Ashvini B. Zadokar, Vaibhav D. Kalam, Mangesh J. Maind, Ashwini R. Borde, Krushna R. Kale
. Abstract This analysis examines the prescription patterns and treatment regimens for tuberculosis (TB), emphasizing the standard first-line therapy comprising isoniazid, rifampicin, pyrazinamide, and ethambutol. The effectiveness of these medications, their potential side effects, and the importance of adherence are discussed. Regular monitoring for hepatotoxicity and other adverse reactions is essential to ensure patient safety. Strategies to improve adherence, such as Directly Observed Therapy (DOT) and patient education, are critical in achieving successful treatment outcomes. Additionally, the analysis highlights the necessity of susceptibility testing to identify drugresistant TB and the potential use of second-line therapies. Ultimately, a comprehensive approach to TB management is vital for effective treatment and reducing transmission. Keywords: Tuberculosis, TB, TB treatment, TB prescription, Isoniazid. [Full Text Article] [Download Certificate] |
